about
TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesisRecurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in miceSTAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model.Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomasRecurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomasTET2, a tumor suppressor in hematological disorders.Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.Hodgkin lymphoma in a sickle cell anaemia child treated with hydroxyurea.Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma.[Recurrent mutations in RHOA and FYN in peripheral T cell lymphomas].Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes.The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma.A somatic mosaicism in the G6PD gene inducing a late onset chronic non-spherocytic hemolytic anemiaAspects moléculaires des lymphomes T périphériques (2)Aspects moléculaires des lymphomes T périphériques (1)Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias[In cauda venenum or the importance of TET(2)]Refractory nodular lymphocyte predominant Hodgkin lymphoma transformed to T-cell/histiocyte-rich B-cell lymphoma in an adolescent: salvage therapy with allogeneic bone marrow transplantationTET2 and DNMT3A mutations in human T-cell lymphomaMutation mismatch repair gene deletions in diffuse large B-cell lymphoma
P50
Q28507642-8D4B512D-3044-495E-82A3-E976591CAF2CQ33402136-F5B17DEC-C228-4F07-B445-076CFEA5B017Q36908743-F39312F7-0595-4C34-B59A-29632ECDF735Q37273194-243DF9B9-2AA0-4B24-B04E-4DB9943B4225Q37612511-1FE67672-1CCE-4C20-8898-10B107C548F7Q37658327-83003CAF-5E0E-44F7-9E01-AA124E4A362FQ37975340-5D772618-A21F-4F10-BDA2-666C720D4A2CQ39349837-D2516FE4-E3AC-46B0-9581-F19859CF1671Q46268561-29876D2F-8F38-4C19-B7FB-96D069A2B2D3Q50791564-99376E65-9CA8-4349-9122-4E4A0201C21EQ53235687-50C5D9D5-874D-4218-BBAF-D0F7CED57739Q53387315-DEBB8F40-92D4-44DF-95D9-50E6B4E35011Q54392737-3C70AA2E-D947-420E-8FFC-2A7E9E8FBB17Q57216434-0667444B-C64D-48E9-A003-C121712E4396Q57216715-78996E60-E73C-493A-ACBE-758116AD30F2Q57216739-D689A4B7-06DA-403D-BD86-E399FA761FE2Q61772125-23FB2CE6-2578-44C2-8B2E-E0795EE6E500Q83112449-FABD0F50-F965-4265-AA06-58A0E643DF70Q83161822-42BDAF55-5588-4AA6-99BF-E02F1F1C3C8FQ83175924-7EA1D3D6-C13A-4B06-B528-1F774BECBCF3Q87445831-9BFC1FD0-1C2D-4190-8EAE-CC65BC67B7DC
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lucile Couronné
@ast
Lucile Couronné
@en
Lucile Couronné
@es
Lucile Couronné
@nl
Lucile Couronné
@sl
type
label
Lucile Couronné
@ast
Lucile Couronné
@en
Lucile Couronné
@es
Lucile Couronné
@nl
Lucile Couronné
@sl
prefLabel
Lucile Couronné
@ast
Lucile Couronné
@en
Lucile Couronné
@es
Lucile Couronné
@nl
Lucile Couronné
@sl
P106
P21
P31
P496
0000-0002-1357-5482